Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home Survey

https://doi.org/10.1016/j.amjopharm.2010.01.001Get rights and content

Abstract

Background: Despite the need for and benefits of medications, polypharmacy (defined here as concurrent use of ≥9 medications) in nursing home residents is a concern. As the number of medications taken increases, so does the risk for adverse events. Monitoring polypharmacy in this population is important and can improve the quality of nursing home care.

Objectives: The aims of this article were to estimate the use of polypharmacy in residents of nursing homes in the United States, to examine the associations between select resident and facility characteristics and polypharmacy, and to determine the leading therapeutic subclasses included in the polypharmacy received by these nursing home residents.

Methods: This was a retrospective, cross-sectional study of a nationally representative sample of US nursing home residents in 2004; the outcome was use of polypharmacy. The 2004 National Nursing Home Survey was used to collect medication data and other resident and facility information. Resident characteristics included age, sex, race, primary payment source, number of comorbidities, number of activities of daily living (ADLs) for which the resident required assistance, and length of stay (LOS) since admission. Facility characteristics included ownership and size (number of beds).

Results: Of 13,507 nursing home residents who received care, 13,403 had valid responses for all 9 independent variables in the analyses. The prevalence of polypharmacy among nursing home residents in 2004 was ~40%. A multiple regression model controlling for resident and facility factors revealed that the odds of receiving polypharmacy were higher for residents who were female (odds ratio [OR] = 1.10; 95% CI, 1.00–1.20), were white, had Medicaid as a primary payer, had >3 comorbidities (OR = 1.57–5.18; 95% CI, 1.36–6.15), needed assistance with <4 ADLs, had an LOS since admission of 3 to <6 months (OR = 1.25; 95% CI, 1.04–1.50), and received care in a small, not- for-profit facility (data not shown for reference levels [OR = 1.00]). The most frequently reported medications for residents who received polypharmacy included gastrointestinal agents (laxatives, 47.5%; agents for acid/peptic disorders, 43.3%), drugs that affect the central nervous system (antidepressants, 46.3%; antipsychotics or antimanics, 25.9%), and pain relievers (nonnarcotic analgesics, 43.6%; antipyretics, 41.2%; antiarthritics, 31.2%).

Conclusions: Despite awareness of polypharmacy and its potential consequences in older patients, results of our analysis suggest that polypharmacy remains widespread in US nursing homes. Although complex medication regimens are often necessary for nursing home residents, monitoring polypharmacy and its consequences may improve the quality of nursing home care and reduce unnecessary health care spending related to adverse events.

References (28)

  • DS Chutka et al.

    Symposium on geriatrics—Part I: Drug prescribing for elderly patients

    Mayo Clin Proc.

    (1995)
  • GG Fillenbaum et al.

    Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population

    J Clin Epidemiol.

    (1996)
  • JT Hanlon et al.

    Suboptimal prescribing in older inpatients and outpatients

    J Am Geriatr Soc.

    (2001)
  • MH Beers et al.

    Explicit criteria for determining inappropriate medication use in nursing home residents

    Arch Intern Med.

    (1991)
  • L Bjerrum et al.

    Polypharmacy: Correlations with sex, age and drug regimen. A prescription database study

    Eur J Clin Pharmacol.

    (1998)
  • JT Hanlon et al.

    Drug-use patterns among black and nonblack community-dwelling elderly

    Ann Pharmacother.

    (1992)
  • EA Chrischilles et al.

    Use of medications by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly

    J Gerontol.

    (1992)
  • LL Dwyer

    Collecting medication data in the 2004 National Nursing Home Survey. National Center for Health Statistics

    Vital and Health Statistics. Series 1

    (March 2009)
  • JA Doshi et al.

    National estimates of medication use in nursing homes: Findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey

    J Am Geriatr Soc.

    (2005)
  • N Krauss
  • DE Tobias et al.

    General and psychotherapeutic medication use in 328 nursing facilities: A year 2000 national survey

    Consult Pharm.

    (2001)
  • 2004 NNHS Resident Table 12. Number and percent distribution of nursing home residents by length of time since admission (in days) and mean and median length of time according to selected resident characteristics: United States

    (2004)
  • DK Helling et al.

    Medication use characteristics in the elderly: The Iowa 65+ Rural Health Study

    J Am Geriatr Soc.

    (1987)
  • Cited by (169)

    • Polypharmacy in Nursing Homes

      2022, Clinics in Geriatric Medicine
    • Age-related changes in peripheral nociceptor function

      2022, Neuropharmacology
      Citation Excerpt :

      As a result of age-related changes in pharmacokinetics and pharmacodynamics, the elderly are more sensitive to adverse effects of drugs (Brahma et al., 2013; Lavan and Gallagher, 2016). In addition, older individuals often take multiple medications (Dwyer et al., 2010; Morgan et al., 2012) that further increase the likelihood of adverse effects due to drug interactions, especially those within the CNS. Medications for the treatment of pain are especially problematic for the elderly.

    • Laxative Agents in Nursing Homes: An Example of Prescribing Cascade

      2021, Journal of the American Medical Directors Association
    • The gut microbiota and nervous system: Age-defined and age-defying

      2021, Seminars in Cell and Developmental Biology
    View all citing articles on Scopus
    View full text